Patents by Inventor Albert Falivene Aldea

Albert Falivene Aldea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9820973
    Abstract: The invention is a pharmaceutical tablet formulation comprising between about 12.5 mg and 100 mg losartan potassium, between about 6.25 mg and about 50 mg chlorthalidone, and sodium bicarbonate in an amount between about 1.0% and about 10.0% by weight.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: November 21, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Jan-Piet Wijgergangs, Jocominus Antonius Maria Zwinkels, Albert Falivene Aldea
  • Publication number: 20170157094
    Abstract: The invention is a pharmaceutical tablet formulation comprising between about 12.5 mg and 100 mg losartan potassium, between about 6.25 mg and about 50 mg chlorthalidone, and sodium bicarbonate in an amount between about 1.0% and about 10.0% by weight.
    Type: Application
    Filed: November 24, 2014
    Publication date: June 8, 2017
    Applicant: Merck Sharp & Dohme B.V.
    Inventors: Jan-Piet Wijgergangs, Jocominus Antonius Maria Zwinkels, Albert Falivene Aldea
  • Publication number: 20150164920
    Abstract: The present invention refers to a controlled release pharmaceutical formulation in solid form comprising Mesalamine. The invention also contemplates the preparation of the said formulation and its use for the treatment of patients suffering from inflammatory bowel disease (IBD).
    Type: Application
    Filed: March 27, 2013
    Publication date: June 18, 2015
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Luis Soler Ranzani, Albert Falivene Aldea, Gemma Casadevall Pujals
  • Patent number: 8846744
    Abstract: The present invention relates to oral pharmaceutical compositions comprising co-crystals of tramadol and celecoxib and processes for the preparation of these oral pharmaceutical compositions. The present invention also relates to methods of using oral pharmaceutical compositions comprising co-crystals of tramadol and celecoxib as medicaments, more particularly for the treatment of pain.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: September 30, 2014
    Assignee: Laboratorios del Dr. Esteve, S.A.
    Inventors: Luis Soler Ranzani, Albert Falivene Aldea
  • Publication number: 20130280325
    Abstract: This invention relates to compressed solid oral dosage form able to contain a high load of active pharmaceutical ingredient, showing a controlled release profile, and consisting of individual particles wherein each individual particle comprises an active pharmaceutical ingredient and wherein each individual particle is coated with a layer comprising at least one plasticizer.
    Type: Application
    Filed: December 22, 2011
    Publication date: October 24, 2013
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Luis Soler Ranzani, Albert Falivene Aldea, Ángel Santanach Delisau, Gemma Casadevall Pujals
  • Publication number: 20130109659
    Abstract: The present invention relates to oral pharmaceutical compositions comprising co-crystals of tramadol and celecoxib and processes for the preparation of these oral pharmaceutical compositions. The present invention also relates to methods of using oral pharmaceutical compositions comprising co-crystals of tramadol and celecoxib as medicaments, more particularly for the treatment of pain.
    Type: Application
    Filed: June 3, 2011
    Publication date: May 2, 2013
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Luis Soler Ranzani, Albert Falivene Aldea